MetaCap

Surrozen Statistics

NASDAQ: SRZNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

28.46-2.21 (-7.21%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Surrozen by the numbers

Surrozen has a market capitalization of $596.4 million based on 20.96M shares outstanding. With trailing EPS of $-41.94, Surrozen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.7% above its 50-day average and 10.1% above its 200-day average.

Average daily trading volume is 537.16K shares, or about $15.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

SRZN valuation vs. peer median

SRZN compared with the median of 8 peer companies
MetricSRZNPeer medianDifference
Market cap$596.40M$576.95M+3%
Avg. volume537.16K637.10K-16%

Peer median across 8 companies: CGEM, FDMT, ENTX, IAM, DBVT, ETRA, ATTO, SLDB.

Valuation

Market cap
$596.40M
Price / sales (latest FY)
171.53
EPS (TTM)
$-41.94

Price and trading

Previous close
30.67
Open
29.92
Day range
28.25 – 30.34
52-week range
12.79 – 37.83
52-week change
+115.61%
Beta
—
Volume
148.85K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
596.40M
Forward Pe
-6.04
Eps
-41.94
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
37.83
Week52 Low
12.79
Avg Volume
537.16K
Shares Outstanding
20.96M
Ma50
26.93
Ma200
25.84
Earnings Date
May 9, 2025
Pct From52w High
-24.77%
Pct From52w Low
122.53%

Related